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Bone is a fundamental component of the disordered joint homeostasis seen in osteoarthri-
tis, a disease that has been primarily characterized by the breakdown of articular cartilage
accompanied by local bone changes and a limited degree of joint inﬂammation. In this
review we consider the role of computed tomography imaging and computational analysis
in osteoarthritis research, focusing on subchondral bone and osteophytes in the hip. We
relate what is already known in this area to what could be explored through this approach in
the future in relation to both clinical research trials and the underlying cellular andmolecular
science of osteoarthritis. We also consider how this area of research could impact on our
understanding of the genetics of osteoarthritis.
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BACKGROUND
Osteoarthritis is a disease that has been primarily characterized
by the breakdown of articular cartilage accompanied by local
bone changes and a limited degree of joint inﬂammation. It is
a leading cause of morbidity causing pain, disability, and loss
of function through chronic, progressive joint degeneration. Hip
joint osteoarthritis causes an enormous health burden, with an
estimated radiographic prevalence of 5% in the population over
65 years of age (Lane, 2007), with actual radiographic and clinical
disease prevalence likely to be much higher (Mannoni et al., 2003;
Dagenais et al., 2009). It has also been identiﬁed as a leading cause
of debilitating pain in the general population (Ingvarsson, 2000).
Previously considered a primary disorder of articular cartilage,
it is now recognized that cartilage, synovium, and bone respond in
concert to mechanical stresses (Samuels et al., 2008), derangement
of which can alter joint homeostasis and lead to the pathological
processes of cartilage destruction, synovitis, and subchondral bone
alteration (Goldring and Goldring, 2007).
Imaging remains an integral part of clinical and research inves-
tigation into osteoarthritis. Each imaging modality has its own
recognized strengths and limitations, but all techniques ultimately
have some contributory value toward advancing our understand-
ing of the disease. In this reviewwe consider the developing role for
computed tomography (CT) imaging and computational analy-
sis in osteoarthritis research, focusing on subchondral bone and
osteophytes in the hip.We relate what is already known in this ﬁeld
to what could be explored through this approach in the future in
relation to both clinical research trials and the underlying cellular
and molecular science of osteoarthritis. We also consider how this
area of research could impact on the genetics of this disease.
DEFINING HIP OSTEOARTHRITIS AND ITS RISK FACTORS
A number of risk factors that predispose to hip osteoarthritis
have been identiﬁed, which have included demographic mea-
sures such as age and sex and more complex interactions between
genetics, lifestyle, and joint morphology (Figure 1). Hip degener-
ation secondary to systemic disorders (e.g., hyperparathyroidism,
acromegaly, and hemochromatosis) and local disorders (e.g.,
Legg–Calvé–Perthes disease, inﬂammatory arthritis, and trau-
matic injury) are also well documented (Lane, 2007). However,
these factors only account for a small fraction of what has been
termed “primary” osteoarthritis, an umbrella term for a variably
painful disease that is poorly deﬁned and whose pathophysiology
is only patchily understood.
Although biochemical biomarkers such as urinary CTX-II (C-
terminal crosslinked telopeptide of type II collagen) and markers
linked to matrix metalloproteinase activity have been able to help
deﬁne subgroups in the heterogeneous population of osteoarthri-
tis sufferers, they have still fallen short of being able to provide
reliably predictive information at the pre-radiographic stage of the
disease, particularly with regard to making a diagnosis in disease-
naïve individuals (Patra and Sandell, 2011). The approach through
genetics and the application of genome-wide association studies
may yet provide insight into new susceptibility loci, but signif-
icant and clinically relevant results are still awaited – see below
(Loughlin, 2011).
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FIGURE 1 | Factors involved in the initiation and progression of hip
osteoarthritis (OA). Aging, mechanical injury, and hereditary factors are all
important when considering the role of morphology in disease initiation.
Subchondral bone changes are now recognized as playing an important role
in early disease and progression. Adapted from Goldring and Goldring
(2007).
If we consider a morphological perspective, it is worth noting
that some structural features of hip osteoarthritis have been rec-
ognized since prehistory (Dequeker and Luyten, 2008). While we
are interested in reﬁning a number of the characteristic anatomi-
cal and morphological features of hip osteoarthritis using current
CT imaging technology, one key problem is that morphological
osteoarthritis does not always produce signiﬁcant symptoms or
lead to relevant clinical outcomes such as joint replacement. Much
work has to be done to identify precisely which morphological
and structural risk factors lead to clinically important outcomes
in hip osteoarthritis. Mechanics and morphology research, hav-
ing ﬁnally translated into the clinic through multi-detector CT
(MDCT) imaging, is ideally suited to addressing this question, the
answers to which are badly needed by the large genetic studies of
osteoarthritis.
SUBCHONDRAL BONE
While cartilage has historically been the principal target tissue in
osteoarthritis research, bone has become increasingly appreciated
as integral to pathogenesis (Samuels et al., 2008). Its structural,
cellular, and biochemical properties are becoming key areas of
research, for example with biomarker analyses demonstrating that
decreased bone synthesis is linked to increased cartilage failure and
that higher bone remodeling activitymay be protective against car-
tilage loss (Patra and Sandell, 2011). Subchondral bone has also
been considered a potential source for the nociceptive signals that
cause disabling pain (Dieppe and Lohmander, 2005). As a result
of this central role in the disease process, bone has also become a
potential target for therapies (Kwan Tat et al., 2010).
Alterations in subchondral bone – seen radiographically as scle-
rosis and cyst formation – were previously thought to be a late
manifestation. However, changes have been detected in this tis-
sue much earlier in the disease process. Subchondral trabecular
bone thickeninghas beenobserved in individualswith osteoarthri-
tis compared to controls (Chiba et al., 2011). Subchondral bone
remodeling has also been detected prior to cartilage degeneration
in an animal model of osteoarthritis (Hayami et al., 2004). Lack
of thickening of the subchondral bone plate has been shown to
be protective against cartilage degeneration in knock-out animals
versus wild type controls in a surgically induced model (Botter
et al., 2009), while Neogi et al. (2009) have demonstrated that
loss of bone resulting in a change of the articular bone shape had a
strong associationwith future cartilage loss in the same sub-region
of the knee over 30months, introducing a potentially predictive
element from determining bone changes. From a biomechani-
cal perspective, the elastic modulus of subchondral bone in the
medial tibial condyle has been demonstrated to be reduced by
60% (hence reduced stiffness) in subjects with overlying cartilage
damage compared to normal controls (Day et al., 2001).
While these studies suggest that changing subchondral bone
characteristics are central to the development and early progres-
sion of osteoarthritis and could be implicated as biomarkers for
future disease, their precise behavior in human osteoarthritis is
yet to be established. This lack of understanding is exempliﬁed
by our knowledge of the relationship between osteoarthritis and
bone mineral density. While the long-standing view has been that
osteoarthritis and osteoporosis have an inverse relationship, with
increased bone density being implicated in cartilage defect devel-
opment (Dore et al., 2009), one recently published opinion is that
both abnormally low and high local bone densities predispose to
osteoarthritis (Herrero-Beaumont et al., 2009). It seems likely that
such contradictions have arisen because of a limited understand-
ing of the true geographical variations in bonemineral density and
variability in applied measurement, for example with increased
bone mineral density in the subchondral bone plate (from reac-
tive sclerosis) being combined with reduced underlying trabecular
bone density (from increased bone turnover) in osteoarthritis.
The relationship of bone stiffness with overlying articular cartilage
damage appears similarly dichotomized (Goldring and Goldring,
2010).
BONE MORPHOLOGY
As a dynamic scaffold to the musculoskeletal system, abnormali-
ties in bone morphology that lead to altered biomechanics are now
well recognized in disease initiation (Ganz et al., 2008). Increased
acetabular anteversion, femoral head asphericity, femoral head–
neck junction deformity, and the “cam” and “pincer” features of
femoro-acetabular impingement (FAI) have all been linked to an
increased risk of developing osteoarthritis (Figure 2; Tönnis and
Heinecke, 1999;Doherty et al., 2008;Ganz et al., 2008; Barros et al.,
2010).
Although FAI is a relative newcomer as an etiological con-
cept (Figure 3), researchers have been aware of aspects of
these morphological features for decades (Solomon, 1976). The
majority of bone morphometry continues to be performed on
plain radiographs (Figure 2), with emphasis on assessing defor-
mity secondary to osteoarthritis for arthroplasty planning rather
than describing primary deformities that may predispose to
osteoarthritis for prognostic evaluation (Gregory et al., 2007).
OSTEOPHYTES
Osteophytes are metaplastic osteo-cartilagenous tissues that form
at the margins of osteoarthritic joints. They have long been
recognized as a key bony contingent of the disease process (Jef-
fery, 1973), however their precise function in pathogenesis is still
unclear and continues to warrant further investigation (Menkes
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and Lane, 2004). One of the key issues yet to be settled is whether
osteophytes occur as a response to altered joint mechanics and
instability (and are thus an attempt at re-stabilization) or whether
they are an undesired side-effect of the anabolic response to an
altered joint milieu that promotes chondrogenesis (van der Kraan
and van den Berg, 2007).
According to one previous radiographic study, the presence
or absence of osteophytes also appeared to deﬁne two distinct
disease phenotypes – hypertrophic and atrophic osteoarthritis
respectively – which raises the question as to why individuals with
osteoarthritis develop osteophytes not only in different distrib-
utions, but also to differing extents (Figure 4; Ledingham et al.,
1992). Another radiographic–histological study described three
main distributions of femoral head osteophytes – epiarticular,
marginal, and subarticular – thatwere each associatedwith speciﬁc
patterns of joint degeneration (Jeffery, 1973).
These variations have not been fully investigated and further
examination of the relationship between osteophytes, joint mor-
phology, and the other features of osteoarthritis could provide fun-
damental insights intopathogenesis at thewhole organ and cellular
levels. In fact, one recent study showed that there was no relation-
ship betweenbonemineral density and the presence of osteophytes
in hip osteoarthritis and called for such further investigation into
the relationship of osteophytes and hip morphology (Okano et al.,
2011).
FIGURE 2 | Morphological abnormalities of the hip joint associated
with hip osteoarthritis that have been demonstrated with plain
radiography: (A) femoral head tilt with reduced acetabular anteversion
which can lead to excessive anterior acetabular coverage; (B) pistol
grip deformity with lack of femoral head sphericity that can lead to
impingement at the superolateral articular cartilage; (C)
developmental dysplasia of the hip with excessive acetabular
anteversion that results in globally deranged biomechanics; (D) the
osseous bump “cam” deformity associated with FAI which also can
lead to impingement at the anterior articular cartilage. Images courtesy
of the Department of Radiology, Addenbrooke’s Hospital, Cambridge.
FIGURE 3 | Diagrammatic representation of the morphological variants
implicated in FAI that lead to increased stress on articular cartilage,
prompting premature breakdown of the normal joint homeostasis and
early development of OA: (A) normal; (B) “pincer” deformity of the
anterior acetabulum; (C) “cam” deformity of the anterior femoral
head–neck junction, afterTannast et al. (2007).
IMAGING BONE IN HIP OSTEOARTHRITIS
Imaging is a vital component of in vivo and ex vivo/in vitro
osteoarthritis research, with the majority of activity having imple-
mented magnetic resonance imaging (MRI) to focus on articular
cartilage and/or plain radiography to screen for disease and grade
and severity (Kellgren and Lawrence, 1957; Hayashi et al., 2011).
While plain radiography is cheap, quick, and available and MRI
is a technique that is excellent at depicting the subchondral bone
marrow lesions found in osteoarthritis (Roemer et al., 2009), both
have drawbacks in the assessment of bone related to osteoarthritis.
PLAIN RADIOGRAPHY
During the decades prior to the widespread application of
MRI, radiographs were the mainstay of osteoarthritis imaging
in research and clinical practice. The ﬁrst published description
of osteoarthritis grading was provided by Kellgren and Lawrence
(1957) and although a few competing radiographic grading sys-
tems have been introduced since, it remains one of the favored
methods (Kellgren and Lawrence, 1957; Tönnis, 1976; Croft et al.,
1990; Reijman et al., 2004). This is also despite the fact that it is
essentially an objective non-quantitative system that has suffered
from the obfuscating effect of a number of different descriptions
being applied to assign a grade score (Schiphof et al., 2008).
As we have seen, plain radiographs remain important in the
assessment of osteoarthritis and have been used in research for
the assessment of bone morphology and osteophyte distribution
(Figures 2 and 4). However, one of the biggest limitations with
respect to modern imaging is that the processes inherent to radi-
ography project a 3D structure as a single 2D representation, in
doing so losing important spatial and morphological information.
MAGNETIC RESONANCE IMAGING
Thanks to its multi-planar capability, the ability to visualize mul-
tiple tissue pathologies and the lack of ionizing radiation, MRI
remains the most important imaging technique in osteoarthritis
(Guermazi et al., 2011). Cortical bone and the subchondral bone
plate are high-density materials with low signal characteristics on
nearly all imaging sequences, while red or yellow marrow signal
usually predominates over trabecular architecture in medullary
bone (Figure 5). The relatively poor spatial resolution of MRI
compared to other imaging modalities, the occurrence of imaging
FIGURE 4 | Radiographically moderate osteoarthritis in hypertrophic
(A) and atrophic (B) forms. Images courtesy of the Department of
Radiology, Addenbrooke’s Hospital, Cambridge.
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artifacts and the lack of speciﬁcity of such signal characteristics
to bone do limit its value: for example, ﬁbrous tissue and metal
susceptibility artifact are usually also low signal,while the ﬂuid sig-
nal of bone marrow lesions can be seen in pathologies other than
osteoarthritis. The full extent of osteophytes can also be difﬁcult to
appreciate without plain radiography for correlation (Figure 5).
The development of MRI at increased magnetic ﬁeld strengths
(3T and subsequently 7T) has improved spatial resolution and
signal-to-noise ratio, but this is at the cost of increased metal
susceptibility and chemical shift artifacts. The latter is an impor-
tant consideration in relation to bone because of the presence
of fat, the subject of this artifact, in yellow bone marrow (Soher
et al., 2007). Nonetheless, promising developments in high ﬁeld
strength imaging have enabled accurate depiction of trabecular
bone micro-architecture at 7T (Chang et al., 2008). One 3T MRI
study looking at the relationship between trabecular bone and
articular cartilage characteristics suggested that overall loss of min-
eralized bone volumewas related to cartilage degeneration (Bolbos
et al., 2008). Another advance has been the application of ultra-
short echo time MRI sequences that are in development for the
visualization of cortical bone with higher spatial resolution and
contrast than conventional sequences (Du et al., 2010). A distin-
guishing feature of this technique is that cortical bone has high
rather than the usual low signal. With the signiﬁcant advantage
of being able to simultaneously image bone and cartilage, MRI
clearly has a developing role to play in the imaging of bone in
osteoarthritis, but does come with limitations.
COMPUTED TOMOGRAPHY
Despite the fact that one study comparing CT with MRI in the
assessment of osteoarthritis severity favored the latter on account
of greater sensitivity, the role of CT in osteoarthritis research
deserves to be reassessed (Chan et al., 1991). It canprovide superior
information about bone structure, including joint morphology
and standard morphometric parameters such as bone volume
fraction and trabecular thickness (Sariali et al., 2009; Chiba et al.,
2011). CT arthrography, although limited in its application from
being an invasive procedure, has also been used in the assessment
of the joint space and articular cartilage and is important clinical
alternative when MRI is contra-indicated (Alvarez et al., 2005).
FIGURE 5 | Marginal osteophytes in a left hip with moderate
osteoarthritis as seen with a coronal T1 sequence (A), a coronal
proton density fat saturation sequence (B), and plain radiography (C).
Marginal osteophytes (arrowheads) are identiﬁable in all three, but MRI
lacks accurate bony deﬁnition, while plain radiography lacks useful 3D
information. Both can underestimate the extent of osteophytosis. Images
courtesy of the Department of Radiology, Addenbrooke’s Hospital,
Cambridge.
In line with technological advances, MDCT now allows for
multi-planar reformatting and 3D reconstruction of bony sur-
faces (Figure 6), which not only circumvent cumbersome steps
required in early CT analysis (e.g., scanning in the prone posi-
tion to align the pelvis in the correct plane; Tönnis and Hei-
necke, 1999), but also provide 3D morphological and topographic
information as a platform for further analysis (see below). This
use of 3D information engenders the same principle behind
volumetric bone mineral density calculation performed with
quantitative CT as opposed to areal bone mineral density as
calculated by dual energy x-ray absorptiometry (DEXA; Lang,
2010), namely the ability to take into account a volume of tis-
sue rather than an area. The correct application of CT could
therefore result in detection of disease features such as sub-
chondral bone plate density change, subchondral cyst formation,
and osteophyte development at much earlier stages than plain
radiography.
What’s more, CT should be able to provide this informa-
tion at increasingly lower radiation doses (Tamm et al., 2011),
with novel techniques for dose reduction being continually devel-
oped – such as multiple low dose acquisitions (Hulme et al.,
2011). However it should be remembered that at a typical effec-
tive dose of around 1–3mSv, MDCT for the purposes of bone
structure and density analysis is a far greater radiation burden
than DEXA at around 0.01mSv per examination (the worldwide
average effective background dose being 2.4mSv/year; Damilakis
et al., 2010). On the back of this, there is a strong epidemi-
ological argument for using CT data in the assessment of hip
osteoarthritis, because a huge number of examinations that cover
the hip joints are performed every day for alternative indica-
tions: here is a wealth of potentially diagnostic and prognostic
information that remains untapped. Free from the constraints of
radiation load, high-resolution CT can also be used to image ex
vivo specimens, for example in cadavers or in samples taken from
individuals with osteoarthritis who have had their joint replaced
(Figure 7).
This is an excellent opportunity to provide comprehensive
3D micro- and macroscopic structural information about the
hip for the purposes of diagnosis and prognostication. While
there has been work on plain radiographs using active shape
FIGURE 6 | Multi-detector CT multi-planar reformatting of the right hip
viewed with a bone window (A) in the axial oblique, (B) coronal
oblique, and (C) sagittal oblique planes with respect to the long axis of
the femoral head and neck; (D) Shaded surface display 3D
reconstruction of the same individual. Note the presence of
degenerative osteophytes at the anterior femoral head–neck junction in
(A,D), early marginal osteophytes at the superior and inferior femoral
head–neck junction in (B) and irregularity of the acetabular rim throughout.
Images courtesy of the Department of Radiology, Addenbrooke’s Hospital,
Cambridge.
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modeling to determine important modes of shape variation in the
proximal femur in relation to the risk of incident radiographic hip
osteoarthritis (Lynch et al., 2009), no published studies have yet
looked at the value of CT in determining morphological predis-
positions to osteoarthritis or its relationship with volumetric bone
mineral density. Furthermore, although no validated CT grading
system of osteoarthritis currently exists, CT could easily be used
to image its bony features, potentially setting a new standard for
grading in epidemiological research and clinical trials.
Osteophyte structure and distribution are prime examples of
bony features in osteoarthritis that would be suitable for analysis
with CT, which (although already performed in part for elbow
osteoarthritis) to the best of our knowledge has not yet been done
in human hip osteoarthritis (Lim et al., 2008). The relationships
between osteophyte distribution,morphology, and deformity have
been examined with plain radiography, but again there have
been no published studies to date that have used CT to further
investigate (Jeffery, 1973).
As with other imaging modalities, there are limitations to CT
such as poor visualization of articular and peri-articular soft tissue
structures and some pathological features such as bone marrow
lesions; imaging with MRI is superior in such instances. However,
one of the most exciting developments afforded by the appli-
cation of CT imaging to osteoarthritis research takes advantage
of its accurate depiction of bone and multi-planar capability,
reprocessing imaging data with promising effects.
FIGURE 7 | Cadaveric high-resolution CT image across the femoral
head–neck junction showing the trabecular bone network centrally
and the distinctive pattern of cortical–trabecular–cortical bone in
marginal osteophytes at the inferior aspect (arrowheads). Image by
Dr Paul Mayhew, from a Densiscan 1000 peripheral Quantitative CT
Scanner, Scanco AG Switzerland. Specimen courtesy of Professor John
Clement, Melbourne Femur collection (Melbourne Dental School, Australia).
COMPUTATIONAL ANALYSIS
Computational analysis techniques are powerful tools that can
be used to assess bony features of the hip joint such as bone
thickness and morphology by creating virtual 3D imaging data
from 2D CT acquisitions. A recently developed technique can
estimate the cortical thickness of the proximal femur from CT
data at multiple surface normal points by assuming a standard-
ized CT attenuation value of cortical bone (Figure 8). One of
the most important aspects of this technique is that cortical
thickness can be accurately modeled from clinical CT data (for
example with a slice thickness of 1mm) down to a sub-pixel res-
olution of 0.3mm (Treece et al., 2010). Cortical bone beneath
articular cartilage is equivalent to subchondral bone and so this
can be applied to measure thickness of the subchondral bone
plate.
Statistical parametric mapping (SPM) can then be used to
compare subchondral bone thickness from case and control sub-
jects, using methods which account for inter-individual vari-
ability in shape using statistical deformation modeling (SDM;
Rueckert et al., 2003). SPM generates regions of interest (ROIs)
that represent signiﬁcantly different thicknesses of bone between
cases and controls. As long as cases are selected on clini-
cally relevant criteria (for instance hip pain or eventual joint
replacement in longitudinal studies), the ROIs are ideally suited
for taking forward into prospective, outcome driven research.
If the ROIs have merit in predicting incident, clinically rel-
evant osteoarthritis, then individual patients can be easily
tested against population averages and disease-speciﬁc criteria
(Figure 9).
FIGURE 8 | Surface normals (cyan) around the neck of the right femur
(imaged with CT), each of which can be used as a point for cortical
thickness measurement; a single measurement is made at the point of
the red line and displayed as the magenta peak in the graph above
(0.57mm). Image courtesy of Dr. GrahamTreece, Department of
Engineering, University of Cambridge.
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Using a technique called B-spline free-form deformation, it
is possible to smoothly warp the virtual surface of a standard-
ized “canonical” femur in an iterative process to match with a
test subject (Figure 10). The most important modes of varia-
tion (usually the top 10%) can be established through principle
component analysis (PCA; Rueckert et al., 2003). These can then
be correlated with important clinical and radiological features
of osteoarthritis, making it possible to establish modes that can
predict osteoarthritis disease and progression.
This was recently successfully performed by Poole et al. (2011)
to determine an increased risk of femoral neck fracture from spe-
ciﬁc sites of cortical thinning in the femoral neck and, given our
developing understanding of the importance of changes in sub-
chondral bone in osteoarthritis, could be translated to assessing for
risk of osteoarthritis development and progression. The thickness
measurement technique could also be developed to assess radio-
logical features of the disease such as osteophyte patterning and,
in combination with the acetabulum, joint space width as novel
imaging biomarkers.
Another promising computational modeling technique that
usesCT imaging data has been developed in collaboration between
engineers and radiologists in Iowa, USA. This has just recently
FIGURE 9 |The process of using SPM to establish ROIs that represent
significant sites of cortical thinning that through clinical application
and validation could be used to assess for the risk of osteoarthritis in a
new individual. Image courtesy of Dr. GrahamTreece, Department of
Engineering, University of Cambridge.
FIGURE 10 | Shape manipulation with B-spline deformation. (A)The
“canonical” proximal femur (red) and the test femur (green) are overlaid. (B)
The “canonical” femur is changed in scale and position to approximate a
best ﬁt. (C)The “canonical” femur is warped through B-spline deformation
to ﬁt the test femur, giving “modes” of variation ranked according to
importance with PCA. Image courtesy of Dr. GrahamTreece, Department of
Engineering, University of Cambridge.
been published, emphasizing the developing importance of such
techniques and collaborationswithinosteoarthritis research.Their
algorithm uses active shape modeling (which can be used to per-
form segmentation) for deﬁning osteophyte growth in the knees
of rabbits with surgically induced osteoarthritis, showing it to be
highly accurate, reproducible, and sensitive in detecting disease
progression (Saha et al., 2011). As of yet, no such studies have
been performed in humans.
RELATING TO CELLULAR AND MOLECULAR ASPECTS OF HIP
OSTEOARTHRITIS
Our current understanding of osteophytes suggests that they orig-
inate from precursor cells in bone periosteum and that their
induction is heavily inﬂuenced by the TGFβ superfamily and bone
morphogenetic proteins (van der Kraan and van den Berg, 2007).
Dickkopf-1 (Dkk1) has also been suggested as having a role in
preventing osteophyte formation in arthritis by adjusting joint
homeostasis toward dampened anabolic repair and promoting
catabolic destruction (Diarra et al., 2007). Detailed research has
been performed into the molecular characterization of different
stages of osteophyte development, with the role of sclerostin as a
Wnt-signaling pathway inhibitor being well established as an anti-
bone-forming molecule (Gelse et al., 2003; Alcaraz et al., 2010).
Recently published work has also shown that osteocyte sclerostin
expression is reduced in hip osteoarthritis, potentially mediating
increased osteoblastic activity in intracapsular bone cortex (Power
et al., 2010). However, it is not known what precise effects scle-
rostin might be having in osteoarthritis in general and osteophyte
development in particular, and how this might relate to bone
remodeling.
Hypertrophic and atrophic forms of osteoarthritis have been
used as a basis for the comparison of cellular and biochemical
aspects of the disease, with Conrozier et al. (2007) using radi-
ographs to categorize subject groups, but this is a rare example.
Accurately establishing valid disease phenotypes according to the
presence and distribution of osteophytes using CT could there-
fore provide important insights into the disturbed biochemical
homeostasis, especially in relation to morphology.
Figure 11 shows the histological appearances of an osteophyte
protruding from the femoral head–neck junction, with dense tra-
becular bone multicellular units (BMUs) beneath a neo-cartilage
cap. As we suggest, abnormal morphology and subchondral bone
would be amenable to imaging analysis with CT and combining
CT with macroscopic analysis of surgically excised or cadaveric
samples may permit comparative studies (such as osteophyte dis-
tribution, cartilage thickness, joint space width, and subchondral
cysts) in the attempt to establish a CT-based grading system of
osteoarthritis. Histological analysis of underlying cartilage and
bone would then be able to provide information to relate imaging
to the severity of disturbed microscopic and ultra-structure.
GENETIC INFLUENCES
While genetic factors are recognized as a component of the multi-
factorial etiology of osteoarthritis, establishing their direct inﬂu-
ence has proved testing, possibly because the process seems to
involve multiple loci, each of which have only a small effect. The
majority of genetic studies in osteoarthritis have focused on the
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FIGURE 11 | ×100Toluidine blue stained section of the femoral
head–neck junction showing an osteophyte with dense trabecular
BMUs (asterisk) and a cartilage cap (arrowheads). Image prepared by
Dr. Linda Skingle; sections cut by Dr. Grant Jordan. Image courtesy of the
Bone Research Group, University of Cambridge.
knee, for example with Neame et al. (2004) estimating a heri-
tability of 0.62 for knee osteoarthritis in their woman sibling
study. One large meta-analysis combining over 8000 patients con-
ﬁrmed that the 7q22 chromosomal region conferred a risk for
knee osteoarthritis, implicating six genes with a possible role in
pathogenesis, with further work yet needed to understand the
molecular pathways that could be involved. The authors of this
meta-analysis also suggested that, because there were a number
of small genetic effects, detecting other possible associations from
minor alleles could require as many as 15,000 subjects, clearly a
signiﬁcant research undertaking (Evangelou et al., 2011).
The genetic heterogeneity observed in osteoarthritis and the
undeﬁned chain of processes from underlying genotype through
expression to phenotype makes this a challenging ﬁeld in which to
tease out associations, especially when they are required to meet
a P value of less than 5× 10−8 in genome-wide association stud-
ies. For these reasons, the role of genetics in determining disease
predisposition remains underpowered, with its relationship with
bone morphology not even yet considered. However, an accu-
rate characterization of pre-disease structural phenotypes as well
as disease pattern phenotypes in hip osteoarthritis would be an
important step in determining genetic inﬂuences, especially for
the new generation of suitably powered genome-wide association
studies that are on the horizon (Loughlin, 2011; Meulenbelt et al.,
2011).
CONCLUSION
Computed tomography provides excellent imaging information
on bone and is ideally suited to the application of novel compu-
tational analysis techniques. In this review, we have argued that
research into hip osteoarthritis will beneﬁt enormously from a
greater application of CT imaging, for example by using morpho-
logical analysis, subchondral bone plate thickness measurement,
and osteophyte patterning to establish valid structural and dis-
ease phenotypes, with the positive implications that this brings for
future molecular and genetic studies.
While no validated CT grading for hip osteoarthritis currently
exists, given the potential for accurate and early depiction of
disease features, there is also strong epidemiological argument
to develop its use in the assessment of hip osteoarthritis, both
clinically and in the setting of research trials.
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